Documents

Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Event/report

Event date

Documents and forms

2025

Q3 2025

Nov 20, 2025

Interim report

Q2 2025

Sep 18, 2025

Interim report

Q1 2025

May 22, 2025

Interim report

Corporate Presentation

Feb 8, 2025

Slides

2024

Q4 2024

Mar 13, 2025

Annual report

Study Update

Dec 12, 2024

Slides

Q3 2024

Nov 7, 2024

Interim report

Corporate Presentation

Sep 12, 2024

Slides

H1 2024

Sep 11, 2024

Interim report

Corporate Presentation

Jul 16, 2024

Slides

Q1 2024

May 15, 2024

Interim report

2023

H2 2023

Mar 13, 2024

Interim report

Corporate Presentation

Nov 30, 2023

Slides

Q3 2023

Nov 29, 2023

Interim report

Corporate Presentation

Oct 17, 2023

Slides

H1 2023

Sep 13, 2023

Interim report

Investor Presentation

Jun 9, 2023

Slides

Q1 2023

May 16, 2023

Interim report

2022

H2 2022

Mar 24, 2023

Interim report

Q3 2022

Nov 23, 2022

Interim report

H1 2022

Sep 29, 2022

Interim report

Q1 2022

May 18, 2022

Interim report

Ryvu Therapeutics SA

Documents